Increased risk of influenza among vaccinated adults who are obese

International Journal of Obesity

Volumn 41, Issue 9, 2017, Pages 1324-1330

  Neidich, S D ^a   Green, W D ^b   Rebeles, J ^b   Karlsson, E A ^c   Schultz Cherry, S ^c   Noah, T L ^d   Chakladar, S ^b   Hudgens, M G ^b   Weir, S S ^d   Beck, M A ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFECTION RISK; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY; POST EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; VACCINE IMMUNOGENICITY; VIRUS STRAIN; COMPLICATION; HEALTH SERVICES RESEARCH; IMMUNOLOGY; INFLUENZA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY;

ADULT; BODY MASS INDEX; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 85028862850     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2017.131     Document Type: Article

References (38)

1. WHO/Influenza (Seasonal). WHO, 2016. http://www.who.int/mediacentre/fact sheets/fs211/en/(accessed November 10 2016)
2. Patterson KD, Pyle GF. The geography and mortality of the 1918 influenza pandemic. Bull Hist Med, 1991, 65 p 4-21.
3. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186.
4. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232-239.
5. Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health 1999; 89: 1715-1721.
6. Sandoval C, Walter SD, Krueger P, Smieja M, Smith A, Yusuf S et al. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. Epidemiol Infect 2007; 135: 574-582.
7. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998; 148: 1094-1102.
8. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302: 1896-1902.
9. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP et al. Populations at risk for severe or uncomplicated influenza illness: systematic review and meta-Analysis. BMJ 2013; 347: f5061.
10. Liu B, Havers F, Chen E, Yuan Z, Yuan H, Ou J et al. Risk factors for influenza A (H7N9) disease-China, 2013. Clin Infect Dis 2014; 59: 787-794.
11. Centers for Disease Control and Prevention. Adult Obesity Facts. https://www.cdc. gov/obesity/data/adult.html (accessed November 10 2016).
12. World Health Organization. Adult Obesity Facts. http://www.who.int/media centre/factsheets/fs311/en/(accessed November 10 2016).
13. Sridhar S, Brokstad KA, Cox RJ. Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel) 2015; 3: 373-389.
14. Trombetta CM, Montomoli E. Influenza immunology evaluation and correlates of protection: A focus on vaccines. Expert Rev Vaccines 2016; 15: 967-976.
15. Coudeville L, Bailleux F, Riche B, Megas F, Andre P, Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian randomeffects model. BMC Med Res Methodol 2010; 10: 18.
16. Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 2011; 30: 1081-1085.
17. Centers for Disease Control and Prevention. Overview of Influenza Surveillance in the United States. http://www.cdc.gov/flu/weekly/overview.htm (accessed 10 November 2016).
18. Webster R, Cox N, Stohr K. World Health Organization Manual on Animal Influenza Diagnosis and Surveillance. WHO: Geneva, 2002.
19. Karlsson EA, Meliopoulos VA, Savage C, Livingston B, Mehle A, Schultz-Cherry S. Visualizing real-Time influenza virus infection, transmission and protection in ferrets. Nat Commun 2015; 6: 6378.
20. R Core Team. R: A Language and Environment for Statistical Computing. 2016.
21. R Foundation for Statistical Computing: Vienna, Austria. https://www.R-project.org/.
22. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005-2014. JAMA 2016; 315: 2284-2291.
23. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
24. Xie H, Wan XF, Ye Z, Plant EP, Zhao Y, Xu Y et al. H3N2 mismatch of 2014-15 northern hemisphere influenza vaccines and head-To-head comparison between human and ferret antisera derived antigenic maps. Sci Rep 2015; 5: 15279.
25. Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: A meta-Analysis. Vaccine 2016; 34: 4835-4841.
26. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006; 39: 137-141.
27. Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine 2015; 33: 4422-4429.
28. Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity 2013; 21: 2377-2386.
29. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012; 36: 1072-1077.
30. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006; 176: 6333-6339.
31. Cheng LW, Huang SW, Huang LM, Chang LY, Shao PL, Kiang D et al. Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine. J Virol Methods 2012; 182: 43-49.
32. Murphy R, Fragaszy EB, Hayward AC, Warren-Gash C. Investigating obesity as a risk factor for influenza-like illness during the 2009 H1N1 influenza pandemic using the Health Survey for England. Influenza Other Respir Viruses 2017; 11: 66-73.
33. Karlsson EA, Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S. Obesity outweighs protection conferred by adjuvanted influenza vaccination. MBio 2016; 7: e01144-16.
34. Smit MA, Wang HL, Kim E, Barragan N, Aldrovandi GM, El Amin AN et al. Influenza vaccine is protective against laboratory-confirmed influenza in obese children. Ped Infect Dis J 2016; 35: 440-445.
35. Callahan ST, Wolff M, Hill HR, Edwards KM. NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis 2014; 210: 1270-1274.
36. Esposito S, Giavoli C, Trombetta C, Bianchini S, Montinaro V, Spada A et al. Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children. Vaccine 2016; 34: 56-60.
37. Talbot H, Coleman L, Crimin K, Zhu Y, Rock MT, Meece J et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 2012; 30: 3937-3943.
38. Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J Leukocyte Biol 2012; 92: 67-73.